磁共振成像技术在预测乳腺癌淋巴血管侵犯中的应用研究进展

doi:10.11904/j.issn.1002-3070.2025.02.013

摘要/Abstract

摘要： 淋巴血管侵犯(lymphatic vascular invasion,LVI)的准确预测及评估对乳腺癌患者的预后极为关键。术后的组织病理学在预测淋巴血管侵犯时存在一定的限制,而磁共振成像(magnetic resonance imaging,MRI)技术凭借其高分辨率和多参数成像的特点,为淋巴血管侵犯的预测和评估提供了更为有效的无创手段。随着放射组学这一研究领域的不断发展,通过深入分析MRI图像显示出的大量放射学特征,并结合患者的临床资料,研究者们构建了更为精确的淋巴血管侵犯预测模型。本文综述了MRI在乳腺癌淋巴血管侵犯预测领域的研究进展,目的是通过术前对淋巴血管侵犯状态的精准识别,为乳腺癌患者的临床治疗提供科学依据,并辅助临床医生制定更适合患者的个性化治疗计划。

关键词: 乳腺癌, 淋巴血管侵犯, 放射组学, 磁共振成像, 预测

Abstract: The accurate prediction and evaluation of lymphatic vascular invasion(LVI)are extremely important for the prognosis of breast cancer patients.Postoperative histopathology has certain limitations in predicting lymphatic vascular invasion,and magnetic resonance imaging(MRI)technology,with its high resolution and multi-parameter imaging characteristics,provides a more effective non-invasive means for the prediction and evaluation of lymphatic vascular invasion.With the continuous development of the research field of radiomics,researchers have constructed a more accurate prediction model of lymphatic vascular invasion by deeply analyzing a large number of radiological features shown in MRI images and combining with the clinical data of patients.This article reviews the recent research progress of MRI in the field of predicting lymphatic vascular invasion of breast cancer.The purpose of this article is to provide a scientific basis for the clinical treatment of breast cancer patients through accurate identification of lymphatic vascular invasion status before surgery,and to assist clinicians in formulating more personalized treatment plans for patients.

Key words: Breast cancer, Lymphatic vascular invasion, Radiomics, Magnetic resonance imaging, Prediction

中图分类号:

R737.9

王铷, 张红霞. 磁共振成像技术在预测乳腺癌淋巴血管侵犯中的应用研究进展[J]. 实用肿瘤学杂志, 2025, 39(2): 162-168.

WANG Ru, ZHANG Hongxia. Research progress on the application of magnetic resonance imaging technology in predicting lymphatic vascular invasion in breast cancer[J]. Journal of Practical Oncology, 2025, 39(2): 162-168.

参考文献

1 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
2 Xia C,Dong X,Li H,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].Chin Med J(Engl.),2022,135(5):584-590.
3 吉雨婷,刘斯文,张芸萌,等.中美两国恶性肿瘤疾病负担、流行趋势及归因风险因素比较[J].中华肿瘤杂志,2024,46(7):646-656.
4 Waks AG,Winer EP.Breast cancer treatment:a review[J].JAMA,2019,321(3):288.
5 Ma Q,Dieterich LC,Detmar M.Multiple roles of lymphatic vessels in tumor progression[J].Curr Opin Immunol,2018,53:7-12.
6 Fujimoto N,Dieterich LC.Mechanisms and clinical significance of tumor lymphatic invasion[J].Cells,2021,10(10):2585.
7 Rakha E A,Martin S,Lee AHS,et al.The prognostic significance of lymphovascular invasion in invasive breast carcinoma[J].Cancer,2012,118(15):3670-3680.
8 程思佳,翟晓阳,周仕豪,等.基于术前MRI特征及定量参数列线图预测乳腺癌患者淋巴血管侵犯[J].磁共振成像,2024,15(5):111-118.
9 王立峰,海梦璐,张孝先,等.乳腺癌淋巴血管浸润的MRI影像研究[J].医药论坛杂志,2024,45(1):109-113.
10 韦姗姗,罗显廷,朱旭娜,等.MRI征象联合炎症指标对肿块型早期浸润性乳腺癌淋巴血管侵犯预测价值[J].广西医科大学学报,2024,41(3):436-443.
11 Du Y,Cai M,Zha H,et al.Ultrasound radiomics-based nomogram to predict lymphovascular invasion in invasive breast cancer:a multicenter,retrospective study[J].Eur Radiol,2024,34(1):136-148.
12 Zhang J,Wang G,Ren J,et al.Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma[J].Eur Radiol,2022,32(6):4079-4089.
13 Zheng H,Jian L,Li L,et al.Delta-radiomics based on dynamic contrast-enhanced MRI for predicting lymphovascular invasion in invasive breast cancer[J].Acad Radiol,2024,31(5):1762-1772.
14 Jiang W,Meng R,Cheng Y,et al.Intra-and peritumoral based radiomics for assessment of lymphovascular invasion in invasive breast cancer[J].J Magn Reson Imaging,2024,59(2):613-625.
15 Aleskandarany MA,Sonbul SN,Mukherjee A,et al.Molecular mechanisms underlying lymphovascular invasion in invasive breast cancer[J].Pathobiology,2015,82(3-4):113-123.
16 Gonzalez J,Bahmad HF,Ocejo S,et al.The usefulness of elastin staining to detect vascular invasion in cancer[J].Int J Mol Sci,2023,24(20):15264.
17 刘冬,张太娟,党计锋.炎症反应驱动乳腺癌转移的研究进展[J].实用肿瘤学杂志,2024,38(05):336-341.
18 Kariri YA,Aleskandarany MA,Joseph C,et al.Molecular complexity of lymphovascular invasion:the role of cell migration in breast cancer as a prototype[J].Pathobiology,2020,87(4):218-231.
19 Kurozumi S,Joseph C,Sonbul S,et al.A key genomic subtype associated with lymphovascular invasion in invasive breast cancer[J].Br J Cancer,2019,120(12):1129-1136.
20 Shi X,Wang X,Yao W,et al.Mechanism insights and therapeutic intervention of tumor metastasis:latest developments and perspectives[J].Signal Transduct Target Ther,2024,9(1):192.
21 Lloyd AJ,Ryan ÉJ,Boland MR,et al.The histopathological and molecular features of breast carcinoma with tumour budding—a systematic review and meta-analysis[J].Breast Cancer Res Treat,2020,183(3):503-514.
22 林颖欣,张月华,张淦梅,等.免疫组化联合半定量法检测淋巴脉管间隙浸润在早期子宫内膜癌的预后价值[J].陆军军医大学学报,2022,44(13):1370-1377.
23 Van den Eynden GG,Van der Auwera I,Van Laere S J,et al.Distinguishing blood and lymph vessel invasion in breast cancer:a prospective immunohistochemical study[J].Br J Cancer,2006,94(11):1643-1649.
24 Kuhn E,Gambini D,Despini L,et al.Updates on lymphovascular invasion in breast cancer[J].Biomedicines,2023,11(3):968.
25 Nishimura R,Osako T,Okumura Y,et al.An evaluation of lymphovascular invasion in relation to biology and prognosis according to subtypes in invasive breast cancer[J].Oncol Lett,2022,24(2):245.
26 Houvenaeghel G,Cohen M,Classe JM,et al.Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer,results from a large,national,multicenter,retrospective cohort study[J].ESMO Open,2021,6(6):100316.
27 Zhong YM,Tong F,Shen J.Lympho-vascular invasion impacts the prognosis in breast-conserving surgery:a systematic review and meta-analysis[J].BMC Cancer,2022,22(1):102.
28 Ryu YJ,Kang SJ,Cho JS,et al.Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy[J].Medicine(Baltimore),2018,97(30):e11647.
29 Wei C,Deng Y,Wei S,et al.Lymphovascular invasion is a significant risk factor for non-sentinel nodal metastasis in breast cancer patients with sentinel lymph node(SLN)-positive breast cancer:a cross-sectional study[J].World J Surg Oncol,2023,21(1):386.
30 Uematsu T,Kasami M,Watanabe J,et al.Is lymphovascular invasion degree one of the important factors to predict neoadjuvant chemotherapy efficacy in breast cancer?[J].Breast Cancer Tokyo Jpn,2011,18(4):309-313.
31 Yang X,Fan X,Lin S,et al.Assessment of lymphovascular invasion in breast cancer using a combined MRI morphological features,radiomics,and deep learning approach based on dynamic contrast‐enhanced MRI[J].J Magn Reson Imaging,2024,59(6):2238-2249.
32 Liu W,Li L,Deng J,et al.A comprehensive approach for evaluating lymphovascular invasion in invasive breast cancer:leveraging multimodal MRI findings,radiomics,and deep learning analysis of intra-and peritumoral regions[J].Comput Med Imaging Graph,2024,116:102415.
33 Ge W,Fan X,Zeng Y,et al.Exploring habitats-based spatial distributions:improving predictions of lymphovascular invasion in invasive breast cancer[J].Acad Radiol,2024:S1076633224003556.
34 Chen Y,Wang L,Luo R,et al.Focal breast edema and breast edema score on T2-weighted images provides valuable biological information for invasive breast cancer[J].Insights Imaging,2023,14(1):73.
35 Liang R,Li F,Yao J,et al.Predictive value of MRI-based deep learning model for lymphovascular invasion status in node-negative invasive breast cancer[J].Sci Rep,2024,14(1):16204.
36 Zhang C,Liang Z,Feng Y,et al.Risk factors for lymphovascular invasion in invasive ductal carcinoma based on clinical and preoperative breast MRI features:a retrospective study[J].Acad Radiol,2023,30(8):1620-1627.
37 Tagliafico AS,Piana M,Schenone D,et al.Overview of radiomics in breast cancer diagnosis and prognostication[J].Breast Edinb Scotl,2020,49:74-80.
38 Lambin P,Leijenaar RTH,Deist TM,et al.Radiomics:the bridge between medical imaging and personalized medicine[J].Nat Rev Clin Oncol,2017,14(12):749-762.
39 Conti A,Duggento A,Indovina I,et al.Radiomics in breast cancer classification and prediction[J].Semin Cancer Biol,2021,72:238-250.
40 Bera K,Braman N,Gupta A,et al.Predicting cancer outcomes with radiomics and artificial intelligence in radiology[J].Nat Rev Clin Oncol,2022,19(2):132-146.
41 Stamoulou E,Spanakis C,Manikis G C,et al.Harmonization Strategies in Multicenter MRI-Based Radiomics[J].J Imaging,2022,8(11):303.
42 Whitney HM,Taylor NS,Drukker K,et al.Additive benefit of radiomics over size alone in the distinction between benign lesions and luminal a cancers on a large clinical breast MRI dataset[J].Acad Radiol,2019,26(2):202-209.
43 Guo W,Li H,Zhu Y,et al.Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data[J].J Med Imaging Bellingham Wash,2015,2(4):041007.
44 Tabnak P,HajiEsmailPoor Z,Baradaran B,et al.MRI-based radiomics methods for predicting Ki-67 expression in breast cancer:a systematic review and meta-analysis[J].Acad Radiol,2024,31(3):763-787.
45 Yu Y,Tan Y,Xie C,et al.Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer[J].JAMA Netw Open,2020,3(12):e2028086.
46 Ma Q,Lu X,Chen Q,et al.Multiphases DCE-MRI radiomics nomogram for preoperative prediction of lymphovascular invasion in invasive breast cancer[J].Acad Radiol,2024,31(12):4743-4758.
47 Ma Q,Li Z,Li W,et al.MRI radiomics for the preoperative evaluation of lymphovascular invasion in breast cancer:A meta-analysis[J].Eur J Radiol,2023,168:111127.
48 Liu Z,Feng B,Li C,et al.Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast‐enhanced‐MRI‐based radiomics[J].J Magn Reson Imaging,2019,50(3):847-857.
49 Tang WJ,Kong QC,Cheng ZX,et al.Performance of radiomics models for tumour-infiltrating lymphocyte(TIL)prediction in breast cancer:the role of the dynamic contrast-enhanced(DCE)MRI phase[J].Eur Radiol,2022,32(2):864-875.
50 Wu Z,Lin Q,Song H,et al.Evaluation of lymphatic vessel invasion determined by D2-40 using preoperative MRI-based radiomics for invasive breast cancer[J].Acad Radiol,2023,30(11):2458-2468.
51 Mann RM,Cho N,Moy L.Breast MRI:state of the art[J].Radiology,2019,292(3):520-536.
52 Kim JY,Kim JJ,Hwangbo L,et al.Diffusion-weighted imaging of invasive breast cancer:relationship to distant metastasis-free survival[J].Radiology,2019,291(2):300-307.
53 Ni-Jia-Ti M,Ai-Hai-Ti D,Huo-Jia A,et al.Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer[J].BMC Cancer,2020,20:94.
54 Durando M,Gennaro L,Cho GY,et al.Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer[J].Eur J Radiol,2016,85(9):1651-1658.
55 Igarashi T,Furube H,Ashida H,et al.Breast MRI for prediction of lymphovascular invasion in breast cancer patients with clinically negative axillary lymph nodes[J].Eur J Radiol,2018,107:111-118.
56 Braman N,Prasanna P,Whitney J,et al.Association of peritumoral radiomics with tumor biology and pathologic response to preoperative targeted therapy for HER2(ERBB2)-positive breast cancer[J].JAMA Netw Open,2019,2(4):e192561.
57 Cheung SM,Husain E,Mallikourti V,et al.Intra-tumoural lipid composition and lymphovascular invasion in breast cancer via non-invasive magnetic resonance spectroscopy[J].Eur Radiol,2021,31(6):3703-3711.
58 Din NMU,Dar RA,Rasool M,et al.Breast cancer detection using deep learning:datasets,methods,and challenges ahead[J].Comput Biol Med,2022,149:106073.
59 Kayadibi Y,Kocak B,Ucar N,et al.MRI radiomics of breast cancer:machine learning-based prediction of lymphovascular invasion status[J].Acad Radiol,2022,29:S126-S134.
60 Zheng H,Jian L,Li L,et al.Prior clinico-radiological features informed multi-modal MR images convolution neural network:a novel deep learning framework for prediction of lymphovascular invasion in breast cancer[J].Cancer Med,2024,13(3):e6932.
61 Jiang D,Qian Q,Yang X,et al.Machine learning based on optimal VOI of multi-sequence MR images to predict lymphovascular invasion in invasive breast cancer[J].Heliyon,2024,10(7):e29267.
62 Jiang Y,Zeng Y,Zuo Z,et al.Leveraging multimodal MRI-based radiomics analysis with diverse machine learning models to evaluate lymphovascular invasion in clinically node-negative breast cancer[J].Heliyon,2024,10(1):e23916.
63 中国抗癌协会乳腺癌专业委员会,中华医学会肿瘤学分会乳腺肿瘤学组.中国抗癌协会乳腺癌诊治指南与规范(2024年版)[J].中国癌症杂志,2023,33(12):1092-1187.
64 Ye DM,Wang HT,Yu T.The application of radiomics in breast MRI:a review[J].Technol Cancer Res Treat,2020,19:1533033820916191.
65 Zhao S,Li Y,Ning N,et al.Association of peritumoral region features assessed on breast MRI and prognosis of breast cancer:a systematic review and meta-analysis[J/OL].Eur Radiol,2024,34(9):6108-6120.

[1]	王锐, 马得原, 贾王强, 关泉林. 纳米医学介导的铜死亡在乳腺癌治疗中的应用和进展[J]. 实用肿瘤学杂志, 2025, 39(2): 144-150.
[2]	王帅, 黎其庆, 李瑞, 许铁峰. 纳米粒子在乳腺癌诊断和治疗中的应用进展[J]. 实用肿瘤学杂志, 2025, 39(2): 151-156.
[3]	谷文, 周澜, 贾燕妮, 黄卫东. QLU-C10D量表在乳腺癌患者中测量属性的验证研究[J]. 实用肿瘤学杂志, 2025, 39(1): 49-55.
[4]	石长勇, 周紫珍, 周广林, 熊益敏. DCE-MRI定量参数联合NCAPH检测诊断早期乳腺癌的价值分析[J]. 实用肿瘤学杂志, 2025, 39(1): 56-60.
[5]	赵倩雯, 佘欣, 耿利军, 彭丹莉, 刘姗姗. 1990—2021年中国胃癌发病趋势的年龄-时期-队列[J]. 实用肿瘤学杂志, 2024, 38(5): 289-294.
[6]	张宇晴, 荆晶, 刘兆良, 安静, 安巍巍. MZB1的可变剪接事件是乳腺癌内分泌治疗耐药的潜在生物标志物[J]. 实用肿瘤学杂志, 2024, 38(5): 313-322.
[7]	杨闽叶, 鲜童丞, 刘景建, 别俊, 王杰, 罗义. IL-23在乳腺癌组织中的表达及其与患者临床病理特征的相关性[J]. 实用肿瘤学杂志, 2024, 38(5): 323-329.
[8]	刘冬, 张太娟, 党计锋. 炎症反应驱动乳腺癌转移的研究进展[J]. 实用肿瘤学杂志, 2024, 38(5): 336-341.
[9]	李倩妮, 徐灵燕, 李健, 姚雪佩, 刘美娜. 乳腺癌多维治疗质量纵向评价的趋势分析[J]. 实用肿瘤学杂志, 2024, 38(4): 213-220.
[10]	高光强, 王发琳, 李娟, 田虹, 果思伽, 于晓兰, 杨婷婷, 刘家仁. β-紫罗兰酮通过NF-κB途径抑制乳腺癌细胞增殖[J]. 实用肿瘤学杂志, 2024, 38(4): 254-261.
[11]	邵禹铭, 朱坤兵, 张洁. SP/NK-1R系统在乳腺癌中的研究进展[J]. 实用肿瘤学杂志, 2024, 38(4): 268-272.
[12]	殷海燕, 淳志明, 马巧君, 成涵, 丁高恒, 张海燕, 刘玉琴. 2019年甘肃省肿瘤登记地区女性乳腺癌流行特征及2010-2019年趋势分析[J]. 实用肿瘤学杂志, 2024, 38(3): 141-148.
[13]	廖俊, 李春峰, 薛英威, 祖洪亮. 乳酸脱氢酶在胃癌诊治中的研究进展[J]. 实用肿瘤学杂志, 2024, 38(3): 200-206.
[14]	黑龙江省医学会乳腺肿瘤学组. 黑龙江省乳腺癌HER2低表达临床病理诊断专家共识(2024版)[J]. 实用肿瘤学杂志, 2024, 38(2): 71-78.
[15]	孟凡岗, 陈飞, 甄立军. DLX2对乳腺癌细胞增殖、迁移、侵袭、凋亡及乳腺癌干细胞特性的影响[J]. 实用肿瘤学杂志, 2024, 38(2): 88-95.